Correction: Clinical outcomes in a primary-level non-communicable disease programme for Syrian refugees and the host population in Jordan: A cohort analysis using routine data.

IF 15.8 1区医学 Q1 Medicine

PLoS Medicine Pub Date : 2024-03-22 eCollection Date: 2024-03-01 DOI:10.1371/journal.pmed.1004373

Éimhín Ansbro, Tobias Homan, David Prieto Merino, Kiran Jobanputra, Jamil Qasem, Shoaib Muhammad, Taissir Fardous, Pablo Perel

引用次数: 0

Abstract

[This corrects the article DOI: 10.1371/journal.pmed.1003279.].

查看原文本刊更多论文

更正：约旦叙利亚难民和东道国人口非传染性疾病初级计划的临床结果：利用常规数据进行的队列分析。

[此处更正了文章 DOI：10.1371/journal.pmed.1003279]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

PLoS Medicine MEDICINE, GENERAL & INTERNAL-

CiteScore

17.60

自引率

0.60%

发文量

227

审稿时长

4-8 weeks

期刊介绍： PLOS Medicine is a prominent platform for discussing and researching global health challenges. The journal covers a wide range of topics, including biomedical, environmental, social, and political factors affecting health. It prioritizes articles that contribute to clinical practice, health policy, or a better understanding of pathophysiology, ultimately aiming to improve health outcomes across different settings. The journal is unwavering in its commitment to uphold the highest ethical standards in medical publishing. This includes actively managing and disclosing any conflicts of interest related to reporting, reviewing, and publishing. PLOS Medicine promotes transparency in the entire review and publication process. The journal also encourages data sharing and encourages the reuse of published work. Additionally, authors retain copyright for their work, and the publication is made accessible through Open Access with no restrictions on availability and dissemination. PLOS Medicine takes measures to avoid conflicts of interest associated with advertising drugs and medical devices or engaging in the exclusive sale of reprints.